➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Mallinckrodt
Colorcon
Merck
McKinsey

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078649


Email this page to a colleague

« Back to Dashboard

NDA 078649 describes SULFACETAMIDE SODIUM, which is a drug marketed by Fougera Pharms, Padagis Us, Taro, Akorn, Alcon Pharms Ltd, Bausch And Lomb, Pharmafair, and Sandoz Inc, and is included in twelve NDAs. It is available from ten suppliers. Additional details are available on the SULFACETAMIDE SODIUM profile page.

The generic ingredient in SULFACETAMIDE SODIUM is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.
Summary for 078649
Tradename:SULFACETAMIDE SODIUM
Applicant:Padagis Us
Ingredient:sulfacetamide sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 078649
Medical Subject Heading (MeSH) Categories for 078649
Suppliers and Packaging for NDA: 078649
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULFACETAMIDE SODIUM sulfacetamide sodium LOTION;TOPICAL 078649 ANDA Perrigo New York Inc 45802-896 45802-896-26 1 BOTTLE, PLASTIC in 1 CARTON (45802-896-26) > 118 mL in 1 BOTTLE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength10%
Approval Date:Mar 23, 2009TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Mallinckrodt
Boehringer Ingelheim
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.